Angi Inc (ANGI) concluded trading on Wednesday at a closing price of $1.63, with 5.55 million shares of worth about $9.04 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -29.74% during that period and on February 12, 2025 the price saw a loss of about -5.78%. Currently the company’s common shares owned by public are about 503.15M shares, out of which, 64.52M shares are available for trading.
Stock saw a price change of -11.41% in past 5 days and over the past one month there was a price change of 4.49%. Year-to-date (YTD), ANGI shares are showing a performance of -1.81% which decreased to -34.01% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.49 but also hit the highest price of $3.10 during that period. The average intraday trading volume for Angi Inc shares is 1.12 million. The stock is currently trading -10.44% below its 20-day simple moving average (SMA20), while that difference is down -7.98% for SMA50 and it goes to -24.98% lower than SMA200.
Angi Inc (NASDAQ: ANGI) currently have 503.15M outstanding shares and institutions hold larger chunk of about 9.96% of that.
The stock has a current market capitalization of $820.13M and its 3Y-monthly beta is at 1.91. PE ratio of stock for trailing 12 months is 22.09, while it has posted earnings per share of $0.07 in the same period. Its PEG reads 2.53 and has Quick Ratio of 2.05 while making debt-to-equity ratio of 0.47. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ANGI, volatility over the week remained 9.47% while standing at 6.80% over the month.
Stock’s fiscal year EPS is expected to drop by -43.81% while it is estimated to increase by 79.82% in next year. EPS is likely to grow at an annualized rate of 8.74% for next 5-years, compared to annual growth of 0.82% made by the stock over the past 5-years.
Coverage by Goldman stated Angi Inc (ANGI) stock as a Neutral in their note to investors on November 13, 2024, suggesting a price target of $2.50 for the stock. On November 13, 2024, Citigroup Downgrade their recommendations, while on July 09, 2024, JMP Securities Initiated their ratings for the stock with a price target of $3.25. Stock get a Neutral rating from UBS on February 15, 2023.
